SurePulse are developing highly accurate heart rate measuring technology designed specifically for babies who need stabilisation or resuscitation at birth. Through increased speed of acquisition and improved accuracy and availability of heart rates during resuscitations, SurePulse can help reduce the time patients spend in neonatal intensive care and reduce costs for healthcare organisations.
Accurate, rapid measurements benefit clinical staff by enabling them to make confident decisions more quickly and to focus on performing procedures in time critical situations.
James Carpenter has served as CEO of SurePulse Medical since its incorporation in mid-2014, having worked to secure considerable grant funding for early development and trials. He has spent 7 years working in medical device engineering and development, particularly focussed on blood flow analysis in the field of Laser Doppler Blood Flowmetry. More recently his work has been centred on high reliability heart rate estimation. He holds a PhD in Electronic Engineering from the University of Nottingham.
Russell Hoyle runs an independent business consultancy advising small and medium sized companies on their strategic development opportunities. As well as being Chairman of SurePulse Medical Ltd, he is a Special Partner with private equity firm Vitruvian Partners LLP, Chairman of UK based electronics manufacturer Tioga Ltd, and a Director of Openbet Technologies Ltd, a software development company to the online gaming market. He is a Board member of the Responsible Gambling Strategy Board, which advises Government and Regulators on policy in relation to research, education and treatment for problem gamblers. Until mid-2010, he was Chairman of Inspired Gaming Group plc, an AIM listed technology provider to the land based gaming market.
George Rice is a licensing executive in the University of Nottingham Technology Transfer team. In 2010 George was recognised as the PraxisUnico 'newcomer of the year' for his contribution to Technology Transfer and in 2011 he won £100k of funding from the UK IPO (the FastForward competition) to collaborate with the Design Council on the use of Design in Technology Transfer. George's background is in process engineering. He received training in technology transfer as a MEDICI fellow. In 2008 George joined the University Technology Transfer Office to develop and manage the unique Technology Demonstrator showcases for University inventions, a project that continues to expand and now has four sites.
Warwick Adams has 30 years experience in the design and manufacture of electronic equipment both in the commercial and medical arena. He started in electronics within the Medical Physics department at the Queens Medical Centre Nottingham and then formed his own business in 1982 designing and manufacturing medical and commercial electronics and systems. Warwick has founded a number of businesses and holds a board position in many of these companies a number of which are certified to ISO 13485. Warwick has also been involved in a number of successful applications and grants for Innovate UK projects with Nottingham University.
Dr Don Sharkey is a Clinical Associate Professor of Neonatal Medicine and honorary consultant neonatologist at Nottingham University Hospitals. He has overseen previous published newborn baby trials in both the Neonatal Intensive Care Unit and delivery room.
Professor Barrie Hayes-Gill has over 30 years expertise in medical electronic devices and has considerable experience of taking devices into the clinic including co-founding Monica Healthcare Ltd that has fully commercialised a fetal heart rate monitor. He has taken several devices through regulatory approvals in the EU (CE) and USA (FDA). He has managed and delivered a number of projects that have underpinned SurePulse's development.